...

Module

Integrating Novel Approaches to Therapy Into the Multidisciplinary Treatment of Sarcomas

Source: Integrating Novel Approaches to Therapy Into the Multidisciplinary Treatment of Sarcomas

Integrating Novel Approaches to Therapy Into the Multidisciplinary Treatment of Sarcomas


Faculty:

Suzanne George, MD
  • Suzanne George, MD

CREDIT INFORMATION

Release Date: 04/14/09

Expiration Date: 04/13/10


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the current limitations of treatment for advanced or metastatic sarcomas and the need for additional therapies
  • Apply clinical trials data evaluating the role of adjuvant chemotherapy according to histological subtype when treating patients with sarcoma
  • Describe the clinical evidence for using molecularly targeted therapies in sarcomas
  • Interpret the latest data on the safety and efficacy of novel targeted therapies for the treatment of sarcomas

Topics covered include:

  • Sarcoma Introduction and Background
  • Conventional Treatment Approaches in Soft Tissue Sarcomas
  • New Chemotherapeutic Agents in Advanced Soft Tissue Sarcoma
  • Emerging Targeted Therapy for Sarcoma
  • Tyrosine Kinase Inhibitors
  • Role of TKIs in the Treatment of GISTs
  • Role of TKIs in the Treatment of Soft Tissue Sarcomas
  • Inhibitors of Heat Shock Protein
  • Inhibition of the mTOR Pathway
  • Antibody Therapies
  • Conclusions

Abstract
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.